Montalbano John S. 4
4 · AbCellera Biologics Inc. · Filed Dec 17, 2020
Insider Transaction Report
Form 4
Montalbano John S.
Director
Transactions
- Award
Stock Option (right to buy)
2020-11-18+500,000→ 500,000 totalExercise: $2.41Exp: 2030-11-18→ Common Shares (500,000 underlying) - Purchase
Common Shares
2020-12-15$20.00/sh+20,000$400,000→ 20,000 total - Purchase
Common Shares
2020-12-15$20.00/sh+5,000$100,000→ 5,000 total(indirect: By Spouse)
Footnotes (4)
- [F1]On December 4, 2020, the Issuer effected a one-for-10 forward stock split of the Issuer's Common Shares ("Stock Split"). This amount has been adjusted to give effect to the Stock Split.
- [F2]The exercise price reported above was converted from the Canadian exercise price of CAD $3.52 using an exchange rate of CAD $1.27840 = US $1.00.
- [F3]The shares subject to such option vest and become exercisable annually in equal installments over a four-year period, with the first tranche vesting on November 18, 2021, subject to the Reporting Person's continuous service to the Issuer on each such date.
- [F4]This transaction occurred prior to the effectiveness of the Issuer's registration under Section 12 of the Securities Exchange Act of 1934 and is being reported on Form 4 solely for purposes of compliance with Rule 16a-2(a) under the Securities Exchange Act of 1934, as amended. The securities covered by such transaction were previously included on the Reporting Person's Form 3.